Nitric oxide transforms serotonin into an inactive form and this affects neuromodulation

Neuroscience

Volumn 93, Issue 2, 1999, Pages 597-603

  Fossier, P ^a   Blanchard, B ^b   Ducrocq, C ^b   Leprince, C ^a   Tauc, L ^a   Baux, G ^a  

^a CNRS   (France)

^b INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

Author keywords

Acetylcholine; Aplysia; Nitric oxide; Serotonin; Serotonin derivatives; Synaptic modulation

Indexed keywords

ARGININE; LINSIDOMINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SEROTONIN; SEROTONIN DERIVATIVE; TETRODOTOXIN;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; APLYSIA; ARTICLE; CHOLINERGIC SYNAPSE; CONTROLLED STUDY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

ACETYLCHOLINE; ANIMALS; APLYSIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; GANGLIA, INVERTEBRATE; MEMBRANE POTENTIALS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; PARASYMPATHETIC NERVOUS SYSTEM; PATCH-CLAMP TECHNIQUES; SEROTONIN; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 0032796998     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00165-7     Document Type: Article

References (42)

1. Arkonac B.M., Kersten J.R., Wynsen J.C., Nighawan N., Waltier D.C. Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside and nitroglycerin. Pharmacology. 52:1996;92-100.
2. Baux G., Fossier P., Tauc L. Histamine and FLRFamide regulate acetylcholine release at an identified synapse in Aplysia in opposite ways. J. Physiol. 429:1990;147-168.
3. Blanchard B., Dendane M., Gallard J.-F., Houee-Levin C., Karim A., Payen D., Launay J.M., Ducrocq C. Oxidation, nitrosation and nitration of serotonin by nitric oxide-derived nitrogen oxides: biological implications in the rat vascular system. Nitric Oxide: Biol. Chem. 1:1997;442-452.
4. Böhme E., Grossmann G., Herz J., Mülsch A., Spies C., Schultz G. Regulation of cyclic GMP formation by soluble guanylate cyclase: stimulation by NO-containing compounds. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 17:1984;259-266.
5. Bohn H., Schönafinger K. Oxygen and oxidation promote the release of nitric oxide from sydnonimines. J. cardiovasc. Pharmac. 14:1989;S6-S12.
6. Bredt D.S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
7. 2+ channel. Neuron. 18:1997;951-958.
8. Brüne B., Lapetina E.G. Activation of cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J. biol. Chem. 264:1989;8455-8458.
9. Burlet S., Cespuglio R. Voltammetric detection of nitric oxide (NO) in the rat brain: its variations throughout the sleep-wake cycle. Neurosci. Lett. 226:1997;131-135.
10. Cespuglio R., Burlet S., Marinesco S., Robert F., Jouvet M. Détection voltamétrique du NO cérébral chez le rat. Variations du signal à travers le cycle veille-sommeil. C. r. hebd Séanc. Acad. Sci., Paris. 319:1996;191-200.
11. De la Breteche M.L., Servy C., Lenfant M., Ducrocq C. Reactivity of nitrite with 2-chlorophenol, t-butyl phenol and resorcinol in mild acidic conditions. Tetrahedron Lett. 35:1994;7231-7232.
12. Demas G.E., Eliasson M.J., Dawson T.M., Dawson V.L., Kriegsfeld L.J., Nelson R.J., Snyder S.H. Inhibition of neuronal nitric oxide synthase increases aggressive behavior in mice. Molec. Med. 3:1997;610-616.
13. D'Ischia M., Costantini C. Nitric oxide-induced nitration of catecholamine neurotransmitters: a key to neuronal degeneration? Bioorg. med. Chem. 3:1995;923-927.
14. Duman R.S., Terwilliger R.Z., Nestler E.J. Endogenous ADP-ribosylation in brain: initial characterization of substrate proteins. J. Neurochem. 57:1991;2124-2132.
15. Dzoljic M.R., De Vries R. Nitric oxide synthase inhibition reduces wakefulness. Neuropharmacology. 33:1994;1505-1509.
16. Dzoljic M.R., van Leeuwen R., De Vries R. Sleep and nitric oxide: effect of 7-nitroindazole - inhibitor of brain nitric oxide synthase. Brain Res. 718:1996;145-150.
17. Dzoljic E., van Leeuwen R., De Vries R., Dzoljic M.R. Vigilance and EEG power in rats: effects of potent inhibitors of the neuronal nitric oxide synthase. Naunyn-Schmiedeberg's Arch. Pharmac. 356:1997;56-61.
18. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. A. Rev. Physiol. 57:1995;683-706.
19. Gerschenfeld H.M., Hamon M., Paupardin-Tritsch D. Release of endogenous serotonin from two identified serotonin-containing neurones and the physiological role of serotonin re-uptake. J. Physiol. 274:1978;265-278.
20. .NO solutions: the nature of the nitrosating intermediates. J. Am. chem. Soc. 118:1996;3419-3425.
21. 2. J. neural Transm., Suppl. 32:1990;249-257.
22. Hölscher C. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci. 20:1997;298-303.
23. Huie R.E., Pajmaja S. The reaction of NO with superoxide. Free Radical Res. Commun. 18:1993;195-199.
24. Ignarro L.J. Biosynthesis and metabolism of endothelium-derived nitric oxide. A. Rev. Pharmac. Toxic. 30:1990;535-560.
25. Kapas L., Fang J., Krueger J.M. Inhibition of nitric oxide synthesis inhibits rat sleep. Brain Res. 664:1994;189-196.
26. Kapas L., Krueger J.M. Nitric oxide donors SIN-1 and SNAP promote nonrapid-eye-movement sleep in rats. Brain Res. Bull. 41:1996;293-298.
27. Kharitonov V.G., Sundquist A.R., Sharma V.S. Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J. biol. Chem. 270:1995;28158-28164.
28. Malinski T., Bailey F., Zhang Z.G., Chopp M. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J. cerebr. Blood Flow Metab. 13:1993;355-358.
29. Meffert M.K., Calakos N.C., Scheller R.H., Schulman H. Nitric oxide modulates synaptic vesicle docking fusion reactions. Neuron. 16:1996;1229-1236.
30. Meulemans A., Mothet J.-P., Schirar A., Fossier P., Tauc L., Baux G. A nitric oxide synthase activity is involved in the modulation of acetylcholine release in Aplysia ganglion neurons: a histological, voltammetric and electrophysiological study. Neuroscience. 69:1995;985-995.
31. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmac. Rev. 43:1991;109-142.
32. 2+ influx and protein kinase G. J. Physiol. 493:1996;769-784.
33. Mothet J.-P., Fossier P., Tauc L., Baux G. Opposite actions of nitric oxide on cholinergic synapses: which pathways? Proc. natn. Acad. Sci. U.S.A. 93:1996;8721-8726.
34. Nelson R.J., Demas G.E., Huang P.L., Fishman M.C., Dawson V.L., Dawson T.M., Snyder S.H. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature. 378:1995;383-386.
35. Schuman E.M., Madison D.V. Nitric oxide and synaptic function. A. Rev. Neurosci. 17:1994;153-183.
36. Shintani F., Kinoshita T., Kanba S., Ishikawa T., Suzuki E., Sasakawa N., Kato R., Asai M., Nakaki T. Bioactive 6-nitronorepinephrine identified in mammalian brain. J. biol. Chem. 271:1996;13561-13565.
37. Suzuki T., Nakajima K., Fujimoto K., Fujii T., Kawashima K. Nitric oxide increases stimulation-evoked acetylcholine release from rat hippocampal slices by a cyclic GMP-independent mechanism. Brain Res. 760:1997;158-162.
38. Tuinier S., Verhoeven W.M.A., van Praag H.M. Serotonin (5-HT) and disruptive behaviour; a critical evaluation of the clinical data. Human Psychopharmac. 11:1996;469-482.
39. Weiss K.R., Cohen J.L., Kupfermann I. Modulatory control of buccal musculature by a serotonergic neuron (metacerebral cell) in Aplysia. J. Neurophysiol. 41:1978;181-203.
40. Williams M.B., Li X., Gu X., Jope R.S. Modulation of endogenous ADP-ribosylation in rat brain. Brain Res. 592:1992;49-56.
41. Wood J., Garthwaite J. Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neuropharmacology. 33:1994;1235-1244.
42. Wrona M.Z., Dryhurst G. Oxidation chemistry of 5-hydroxytryptamine. J. org. Chem. 52:1987;2817-2825.